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Abstract
Background: Radiotherapy in the radical doses can produce severe and often irreversible damage
to the gut in the form of fibrosis, necrosis and fistulae formation. A previous pelvic surgery makes
the gut extra-vulnerable. This is on account of adhesions to the pelvic wall, unless special care is
taken during surgery to keep it out of the harms way, during adjuvant radiotherapy. These effects
range from acute, to sub acute and delayed chronic manifestations like in the reported case.
Case report: A spontaneous low out put enterocutaneous fistula in a 68-year-old man following
surgery and adjuvant radiotherapy given 27 years back for carcinoma penis is reported. Patient is
making a satisfactory progress after three years of follow-up.
Conclusion: High dose external beam radiotherapy is known to produce deleterious side effects
ranging from mild radiation enteritis to the development of internal and external fistulae. The
effects may be acute, subacute or chronic. Presentation as spontaneous enterocutaneous fistula 27
years after radiotherapy is rare.
Introduction
The damage caused by external beam radiation to the gut
particularly in the dosages required for tumor regression
i.e. ranging from 40–60 Gy is often severe and irreversible.
This may manifest in the form of fibrosis, necrosis and fis-
tulae formation in the bowel [1,2]. It is worse in immuno-
compromised patients like diabetics, patients receiving
chemotherapy and following radiotherapy. Previous pel-
vic surgery like for carcinoma ovary, cervix and rectum etc.
makes the gut extra vulnerable because of formation of
adhesions to the pelvis [1–4]. Presentation of radiation-
induced damage to the gut may be acute, subacute or
chronic and sometimes unusually delayed [3,4]. The max-
imum time lapse before development of enterocutaneous
fistula following radiotherapy reported in the world liter-
ature is 15 years [5,6]. Presentation 27 years after receiving
radiotherapy is rare.
Case report
A 65-year-old normally built gentleman presented to the
outpatient with sudden onset discharge of faecal contents
from an opening in the left inguinal region. The oral
intake was adequate and he was passing stools and urine
normally. There was no history suggestive of diabetes
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mellitus, tuberculosis or Crohn's disease. It started as a
red, painful swelling in the inguinal region three days
back, which ruptured spontaneously discharging faecal
contents. Patient had undergone total penectomy with
bilateral orchiectomy and perineal urethrostomy, 27 years
earlier for carcinoma of the penis, followed by 60 Gy adju-
vant external beam radiotherapy (EBRT) to the pelvis and
para aortic nodes in 30 fractions. He was on a regular fol-
low-up except for the last five years when he was lost to
follow-up.
Examination revealed a well preserved; 140 lbs man
(height 165 cm) with no features of anemia, hypopro-
teinemia, dehydration or electrolyte disturbances. His
performance status was good and nutrition risk index
(NRI) was >90 (NRI = 1.519 × Serum albumin (g/l) +
0.417 × (current wt/usual wt) × 100). Based on subjective
global assessment (SGA) (including clinical criteria like
weight loss in previous six months, recent dietary intake
compared to the usual intake, presence of anorexia etc.)
and Eastern Cooperative Oncology Group (ECOG) crite-
ria his performance and nutritional status was good.
Abdomen was scaphoid with no organomegaly or any
lymphadenopathy.
There was a discharging fistulous opening in the left ilio-
inguinal area approximately 5 cm from the pubic symph-
ysis (figure 1). The discharge was faecal with no evidence
of pus in it. The routine investigations including the blood
biochemistry were normal. Abdominal ultrasound was
normal. Contrast enhanced computed tomography
(CECT) abdomen (figure 2) revealed an enterocutaneous
fistula and there was no evidence of any recurrent or rem-
nant disease. Fistulogram (figure 3) confirmed the com-
munication with the small bowel. Since the patient was
well preserved, with good performance and nutritional
status, with adequate oral intake, features of intestinal
obstruction, evidence of any underlying malignancy and
it being a low output fistula (with a daily out put less than
100 ml), he was managed conservatively on expectant
treatment.
Fistulous opening in the left inguinal region (ileal contents can be seen coming out of the fistulous opening) Figure 1
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The general management included replenishment of fluid
and electrolyte losses, and nutritional supplements. The
local skin care involved using skin protective emollients
creams (containing dimethicone 20%, zinc oxide 7.5%,
calamine 1.5% and cetrimide 1.125%) and egg white
around the fistula site to protect the skin. An ileostomy
bag was fitted in order to allow the fistula to close sponta-
neously and to measure the output in 24 hours accurately.
The daily intake and output chart was maintained to accu-
rately assess the loss for replacement. He made a satisfac-
tory recovery with the output gradually reducing to less
than 5 ml and was discharged on the tenth day. Patient
has made a satisfactory recovery and now has completed
three years on follow-up.
Discussion
The damage caused to the gut by external beam radiother-
apy to the pelvis when used in tumoricidal doses (40–60
Gy) is severe and often irreversible. The damage observed
is more severe in patients receiving radiotherapy after
prior pelvic surgery like in advanced cancer of the cervix
where a combination of radiation therapy and pre-treat-
ment surgical staging is done in women with advanced
disease [1,2]. The major underlying cause of these sponta-
neous enterocutaneous fistulae is pelvic malignancies, in
particular, cancer of the cervix where the formation of
spontaneous enterocutaneous fistulae following radio-
therapy is highest [3–6]. There is a very strong correlation
between pre-treatment surgical staging and radiation dose
[3,5–8]. Fractionated doses of 30–40 Gy can cause dam-
age to the gut. Severe damage may follow dosages more
than 60 Gy. In day-to-day routine practice one refers to
the tolerance doses documented by Rubin and Cassarett
[5] as TD 5/5 which indicates the probability of 5% com-
plication rates within five years and TD 50/5 indicating
the probability of 50% complication rates within five
years.
In an effort to achieve an uncomplicated loco-regional
tumor control it is important to minimize the radiation to
normal structures while maximizing the dose to the
tumor. The development of computers and modern imag-
Contrast enhanced computed scan showing the enterocutaneous fistula and no evidence of any remnant or recurrent disease Figure 2
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ing techniques has led to the evolution of a "three dimen-
sional treatment planning and dose delivery" system,
which may eventually assist radiation oncologist in
achieving this goal [5].
In addition to the potential for an increased morbidity
and mortality, the development of fistula in a cancer
patient can prohibit any definitive or surgical treatment
for the underlying malignancy and attempts at closure of
the fistula [6–9]. Further more immunocompromised
states or nutritional deficiencies in these patients may
reduce the likelihood of fistula resolution. Development
of an enterocutaneous fistula in a patient with active dis-
ease may also limit the ability of patient to proceed with
adjuvant curative or palliative treatment [6]. Fistula occur-
ring after 30 days of the primary therapy i.e. either surgery
or radiotherapy is defined as spontaneous enterocutane-
ous fistula [8].
Enterocutaneous fistulae are classified into four types
based on the modified Sitges-Serra classification [8] pro-
posed by Shein and Decker [6–8]. Type 1 fistula are
esophageal, gastric, and duodenal fistulae, type II fistula
Involve small bowel; type III fistula Involve large bowel
and type IV fistula where all the afore mentioned drains
through a large abdominal wall defect.
Based on the output, the fistulas are classified as high and
low output fistula. Fistulae producing less than 500 cc
output per day are classified as low output fistulae while
those with >500 ml/ day are classified as high output fis-
tulae and this has a bearing on the management [8]. High
out put fistulas usually require surgical intervention while
low output fistulae in well-preserved individuals may be
managed conservatively [6–8].
The presentation may be in the form of fibrosis, necrosis
and fistulae of the bowel. Pelvic surgery for carcinoma cer-
vix, rectum or ovary makes the gut extra vulnerable due to
adhesions to the pelvic walls unless special care is taken
during surgery to keep the small bowel out of the harms
way [1,2]. Various parts of the gut in the order of increas-
ing tolerance to radiations are jejunum, ileum, transverse
colon and rectum [2,6–8]. The time interval between irra-
diation and the clinical manifestation of bowel injury can-
not be predicted and is divided in to four distinct phases
of radiation effects [1,7,9]. Acute Phase, where mainly the
mucosa is affected in the form of acute radiation mucosi-
tis, sub acute phase occurring over a period of one to two
years, affecting predominantly the submucosa and a
chronic phase affecting all layers of the bowel. The chronic
phase usually occurs within three to four years following
irradiation.
Late chronic effects are in the form of progressive obliter-
ative endarteritits and ischemia. The resultant damage
ranges from chemical cellulitis, ulceration, fibrosis and
necrosis of the bowel wall to fistulae formation. The
reported case falls in to this category.
Management of fistulas is divided into three phases: Phase
I involves the correction of fluid and electrolyte imbal-
ances. The fistula drainage is accurately measured and
replaced milliliter by milliliter with normal saline. Metic-
ulous skin care is provided around the fistula using skin
protective creams. Ileostomy bag is placed on the opening
to allow for evaluation of spontaneous closure and mon-
itoring the daily output. The associated intra-abdominal
abscesses are drained and appropriate antibiotics started.
Phase II consists of accurate diagnosis of the origin of fis-
tula and begins simultaneously with phase I. The diagno-
sis of the fistula can be accomplished by using water-
soluble iodinated media through a small catheter inserted
in to the fistulous opening (fistulogram). Because of the
rapid absorption of the water-soluble material, x-ray
should be taken immediately. Combination with barium
studies can accurately establish the site of the fistula in
case of difficulty. CECT can delineate the fistula and also
Fistulogram showing the communication with the small  bowel Figure 3
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locate any recurrent or remnant tumor. Hyperalimenta-
tion is initiated and observation regarding the possibility
of spontaneous closure of the fistula is done during this
phase. The fistula closes spontaneously if there is no distal
obstruction, no underlying malignancy, and no foreign
body in the intestinal wall, if the fistula tract is not lined
by fibrous tissue, if the fistulous opening is not very large
(<1 cm) and if there is no eversion of mucous membrane
and epithelialization of the fistulous tract. All these condi-
tions in addition to high output are an indication for sur-
gery, which is a part of phase III [6–9].
The phase III consists of surgical correction and the princi-
ples are well established barring a few controversies
regarding the type and extent of the surgical procedure to
be undertaken. Bypass surgery is not recommended as the
damage may be difficult to predict correctly and therefore
it has a high failure rate, high mortality and causes blind
loop syndrome. Furthermore leaving behind the diseased
bowel may act as a possible source of further complica-
tions. Therefore resection of the matted diseased bowel
with anastomosis of healthy segments is considered a bet-
ter option. In critically ill patients, exteriorization of both
ends (as ostomy and mucus fistula) is considered worth-
while, in order to have the patient for definitive repair
when he is clinically stable. This is also applied to rectal
irradiation injuries where Hartman's procedure may be
contemplated [8–11].
The extent of damage in a radiation-injured bowel is diffi-
cult to predict and the injury usually may be more severe
than anticipated, the successful management of these
cases therefore requires an early diagnosis and carefully
staged planning for treatment [2,3].
The maximum time lapse reported between exposure to
radiotherapy and development of radiation induced
enteropathy in the form of enterocutaneous fistula is 15
years [5,6]. The development of a spontaneous enterocu-
taneous fistula 27 years after radiotherapy is rare and to
the best of our knowledge this is the first report of such a
delayed presentation.
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